Skip to content

Nancy S. Tarlin, M.D.

NPI 1063426641ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Elmhurst, NY

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Elmhurst, New York, licensed in NY, with an NPI issued in July 2006. Their prescriptions cost Medicare Part D more than their services did: $1,006,367 for 2,264 claims, against $128,456 paid for services in 2024. Novo Nordisk Inc reported $29.67 in payments in 2024, mostly food and beverage.

Overview

NPI1063426641
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedJul 28, 2006
Last updated in NPPESDec 11, 2007

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (NY)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients416
Services billed3,450 across 17 procedure codes
Paid by Medicare$128,456

Part D prescriptions in 2024

Prescriptions (claims)2,264 · 5,221 30-day fills
Patients346
Total drug cost$1,006,367
Generic share51% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$29.67 · 2 payments from 1 company

Top paying companies in 2024

CompanyAmountPayments
Novo Nordisk Inc$29.672

What the 2024 payments were for

  • Food and Beverage$29.67 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other endocrinologists in Elmhurst

All endocrinologists in New York